INGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 40 cases where INGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 75%.
The 10-day moving average for INGN crossed bullishly above the 50-day moving average on October 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +5.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where INGN advanced for three days, in 190 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 115 of 169 cases where INGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
The 10-day RSI Indicator for INGN moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 25 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 58 cases where INGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INGN as a result. In 70 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for INGN turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 39 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.915) is normal, around the industry mean (4.142). P/E Ratio (-6.626) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.393) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. INGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
OFIX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 02, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In 46 of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 87%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OFIX as a result. In 71 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
OFIX moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OFIX crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The RSI Indicator entered the oversold zone -- be on the watch for OFIX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFIX advanced for three days, in 202 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
OFIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 112 of 149 cases where OFIX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. OFIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.747) is normal, around the industry mean (4.142). P/E Ratio (-5.178) is within average values for comparable stocks, (3.291). OFIX's Projected Growth (PEG Ratio) (48.825) is slightly higher than the industry average of (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.431) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
INGN | OFIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 31 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 94 | |
PRICE GROWTH RATING 1..100 | 58 | 79 | |
P/E GROWTH RATING 1..100 | 37 | 14 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INGN's Valuation (53) in the Medical Specialties industry is somewhat better than the same rating for OFIX (98). This means that INGN’s stock grew somewhat faster than OFIX’s over the last 12 months.
INGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as OFIX (100). This means that INGN’s stock grew similarly to OFIX’s over the last 12 months.
INGN's SMR Rating (94) in the Medical Specialties industry is in the same range as OFIX (94). This means that INGN’s stock grew similarly to OFIX’s over the last 12 months.
INGN's Price Growth Rating (58) in the Medical Specialties industry is in the same range as OFIX (79). This means that INGN’s stock grew similarly to OFIX’s over the last 12 months.
OFIX's P/E Growth Rating (14) in the Medical Specialties industry is in the same range as INGN (37). This means that OFIX’s stock grew similarly to INGN’s over the last 12 months.
| INGN | OFIX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 74% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 74% |
| Advances ODDS (%) | 8 days ago 71% | 8 days ago 71% |
| Declines ODDS (%) | 6 days ago 81% | 6 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 75% | 2 days ago 70% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 75% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INGN’s FA Score shows that 0 FA rating(s) are green while OFIX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INGN’s TA Score shows that 4 TA indicator(s) are bullish while OFIX’s TA Score has 5 bullish TA indicator(s).
INGN (@Medical/Nursing Services) experienced а -14.53% price change this week, while OFIX (@Medical/Nursing Services) price change was -18.72% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
INGN is expected to report earnings on Feb 25, 2027.
OFIX is expected to report earnings on Feb 19, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, INGN has been loosely correlated with IRTC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then IRTC could also see price increases.
| Ticker / NAME | Correlation To INGN | 1D Price Change % | ||
|---|---|---|---|---|
| INGN | 100% | -1.88% | ||
| IRTC - INGN | 47% Loosely correlated | -3.01% | ||
| VCYT - INGN | 46% Loosely correlated | -7.18% | ||
| STRRP - INGN | 44% Loosely correlated | +0.89% | ||
| OSUR - INGN | 39% Loosely correlated | -5.67% | ||
| OFIX - INGN | 38% Loosely correlated | -9.87% | ||
More | ||||
A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with SYK. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then SYK could also see price increases.
| Ticker / NAME | Correlation To OFIX | 1D Price Change % | ||
|---|---|---|---|---|
| OFIX | 100% | -9.87% | ||
| SYK - OFIX | 50% Loosely correlated | -0.44% | ||
| ENOV - OFIX | 48% Loosely correlated | -1.12% | ||
| ATEC - OFIX | 47% Loosely correlated | -5.15% | ||
| PODD - OFIX | 46% Loosely correlated | -1.17% | ||
| MMSI - OFIX | 46% Loosely correlated | -0.69% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VOE | 211.20 | N/A | N/A |
| Vanguard Morningstar Mid-Cap Value ETF (VOE) | |||
| RNIN | 38.19 | -0.01 | -0.03% |
| Bushido Capital US SMID Cap Equity ETF (RNIN) | |||
| JULJ | 24.86 | -0.04 | -0.18% |
| Innovator Premium Income 30 Barrier ETF - July (JULJ) | |||
| LQDI | 25.01 | -0.21 | -0.83% |
| iShares Inflation Hedged Corporate Bond ETF (LQDI) | |||
| AIS | 53.31 | -0.82 | -1.51% |
| VistaShares Artificial Intelligence Supercycle ETF | |||